Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionATP-dependent activity

NAV3 MYH10 NAV2 MYH14

9.86e-0561494GO:0140657
GeneOntologyMolecularFunctionmicrofilament motor activity

MYH10 MYH14

1.26e-043892GO:0000146
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYH10 MYH14

1.21e-0311892GO:0003774
GeneOntologyMolecularFunctionactin filament binding

MYH10 MYH14

4.39e-0322792GO:0051015
GeneOntologyMolecularFunctioncalmodulin binding

MYH10 MYH14

4.51e-0323092GO:0005516
GeneOntologyMolecularFunctioncytoskeletal protein binding

NAV3 MYH10 MYH14

1.09e-02109993GO:0008092
GeneOntologyCellularComponentmyosin II filament

MYH10 MYH14

4.94e-07392GO:0097513
GeneOntologyCellularComponentmyosin filament

MYH10 MYH14

4.92e-052592GO:0032982
GeneOntologyCellularComponentmyosin II complex

MYH10 MYH14

6.19e-052892GO:0016460
GeneOntologyCellularComponentmyosin complex

MYH10 MYH14

2.78e-045992GO:0016459
GeneOntologyCellularComponentcontractile actin filament bundle

MYH10 MYH14

9.13e-0410792GO:0097517
GeneOntologyCellularComponentstress fiber

MYH10 MYH14

9.13e-0410792GO:0001725
GeneOntologyCellularComponentactomyosin

MYH10 MYH14

1.09e-0311792GO:0042641
GeneOntologyCellularComponentactin filament bundle

MYH10 MYH14

1.11e-0311892GO:0032432
GeneOntologyCellularComponentbrush border

MYH10 MYH14

1.83e-0315292GO:0005903
GeneOntologyCellularComponentGolgi membrane

RNF121 MGAT2 NDST2

2.94e-0372193GO:0000139
GeneOntologyCellularComponentcluster of actin-based cell projections

MYH10 MYH14

3.88e-0322392GO:0098862
GeneOntologyCellularComponentgrowth cone

MYH10 MYH14

4.66e-0324592GO:0030426
GeneOntologyCellularComponentsite of polarized growth

MYH10 MYH14

4.97e-0325392GO:0030427
GeneOntologyCellularComponentsupramolecular fiber

NAV3 MYH10 MYH14

1.16e-02117993GO:0099512
GeneOntologyCellularComponentsupramolecular polymer

NAV3 MYH10 MYH14

1.18e-02118793GO:0099081
DomainMyosin_N

MYH10 MYH14

2.70e-0515102IPR004009
DomainMyosin_N

MYH10 MYH14

2.70e-0515102PF02736
DomainMyosin_tail_1

MYH10 MYH14

3.93e-0518102PF01576
DomainMyosin_tail

MYH10 MYH14

3.93e-0518102IPR002928
DomainP-loop_NTPase

NAV3 MYH10 NAV2 MYH14 NDST2

3.97e-05848105IPR027417
DomainMyosin-like_IQ_dom

MYH10 MYH14

4.39e-0519102IPR027401
Domain-

MYH10 MYH14

4.39e-05191024.10.270.10
DomainMYOSIN_MOTOR

MYH10 MYH14

1.80e-0438102PS51456
DomainMYSc

MYH10 MYH14

1.80e-0438102SM00242
DomainMyosin_head

MYH10 MYH14

1.80e-0438102PF00063
DomainMyosin_head_motor_dom

MYH10 MYH14

1.80e-0438102IPR001609
DomainCH

NAV3 NAV2

5.27e-0465102SM00033
DomainCH

NAV3 NAV2

6.11e-0470102PF00307
DomainIQ

MYH10 MYH14

6.29e-0471102PF00612
Domain-

NAV3 NAV2

6.29e-04711021.10.418.10
DomainCH

NAV3 NAV2

6.64e-0473102PS50021
DomainCH-domain

NAV3 NAV2

7.01e-0475102IPR001715
DomainIQ

MYH10 MYH14

8.17e-0481102SM00015
DomainIQ_motif_EF-hand-BS

MYH10 MYH14

1.01e-0390102IPR000048
DomainIQ

MYH10 MYH14

1.08e-0393102PS50096
DomainAAA+_ATPase

NAV3 NAV2

2.55e-03144102IPR003593
DomainAAA

NAV3 NAV2

2.55e-03144102SM00382
Domain-

NAV3 NAV2 NDST2

6.17e-037461033.40.50.300
PathwayREACTOME_RHO_GTPASES_ACTIVATE_ROCKS

MYH10 MYH14

3.60e-051972M27493
PathwayREACTOME_RHO_GTPASES_ACTIVATE_CIT

MYH10 MYH14

3.60e-051972M27489
PathwayREACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE

MYH10 MYH14

4.00e-052072M18415
PathwayREACTOME_RHO_GTPASES_ACTIVATE_PAKS

MYH10 MYH14

4.42e-052172M27494
PathwayREACTOME_RHO_GTPASES_ACTIVATE_PAKS

MYH10 MYH14

5.32e-052372MM15222
PathwayREACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING

MYH10 MYH14

5.80e-052472M2243
PathwayREACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE

MYH10 MYH14

8.53e-052972M27309
PathwayREACTOME_SEMAPHORIN_INTERACTIONS

MYH10 MYH14

4.20e-046472M7923
PathwayKEGG_VIRAL_MYOCARDITIS

MYH10 MYH14

5.02e-047072M12294
PathwayREACTOME_EPH_EPHRIN_SIGNALING

MYH10 MYH14

8.66e-049272M27201
PathwayREACTOME_RHO_GTPASES_ACTIVATE_PKNS

MYH10 MYH14

8.85e-049372M27487
PathwayKEGG_TIGHT_JUNCTION

MYH10 MYH14

1.77e-0313272M11355
PathwayKEGG_REGULATION_OF_ACTIN_CYTOSKELETON

MYH10 MYH14

4.54e-0321372M18306
PathwayREACTOME_RHO_GTPASE_EFFECTORS

MYH10 MYH14

6.54e-0325772MM14755
PathwayREACTOME_RHO_GTPASE_EFFECTORS

MYH10 MYH14

1.02e-0232372M27080
Pubmed

Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.

MYH10 MYH14

7.44e-08210220861308
Pubmed

Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition.

MYH10 MYH14

7.44e-08210222025714
Pubmed

Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity.

MYH10 MYH14

7.44e-08210215880105
Pubmed

Planar polarity of multiciliated ependymal cells involves the anterior migration of basal bodies regulated by non-muscle myosin II.

MYH10 MYH14

2.23e-07310220685736
Pubmed

Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.

MYH10 MYH14

2.23e-07310214594953
Pubmed

Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans.

NAV3 NAV2

2.23e-07310212079279
Pubmed

Characterization of three full-length human nonmuscle myosin II paralogs.

MYH10 MYH14

2.23e-07310224072716
Pubmed

Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.

NAV3 NAV2

2.23e-07310215158073
Pubmed

Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms.

NAV3 NAV2

2.23e-07310212062803
Pubmed

Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.

MYH10 MYH14

2.23e-07310215177565
Pubmed

Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.

MYH10 MYH14

2.23e-07310215774463
Pubmed

Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.

MYH10 MYH14

2.23e-07310215845534
Pubmed

Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.

MYH10 MYH14

4.46e-07410218697221
Pubmed

Myosin II regulates extension, growth and patterning in the mammalian cochlear duct.

MYH10 MYH14

7.44e-07510219439495
Pubmed

Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development.

MYH10 MYH14

7.44e-07510233871354
Pubmed

Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption.

MYH10 MYH14

7.44e-07510225006807
Pubmed

A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons.

MYH10 MYH14

1.12e-06610215034141
Pubmed

Nonmuscle myosin II regulation of lung epithelial morphology.

MYH10 MYH14

1.12e-06610222972683
Pubmed

Replacing nonmuscle myosin 2A with myosin 2C1 permits gastrulation but not placenta vascular development in mice.

MYH10 MYH14

1.12e-06610230044719
Pubmed

Nonmuscle myosin II isoform and domain specificity during early mouse development.

MYH10 MYH14

1.56e-06710220679233
Pubmed

Dynamic microtubules catalyze formation of navigator-TRIO complexes to regulate neurite extension.

NAV3 NAV2

1.56e-06710225065758
Pubmed

Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice.

MYH10 MYH14

2.08e-06810217429076
Pubmed

Convergence and extrusion are required for normal fusion of the mammalian secondary palate.

MYH10 MYH14

2.08e-06810225848986
Pubmed

A point mutation in Myh10 causes major defects in heart development and body wall closure.

MYH10 MYH14

3.34e-061010224825879
Pubmed

Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

MYH10 MYH14

4.90e-06121028424456
Pubmed

PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium.

MYH10 MYH14

6.76e-061410222560610
Pubmed

Patterning and folding of intestinal villi by active mesenchymal dewetting.

MYH10 MYH14

7.80e-061510238781967
Pubmed

Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons.

MYH10 MYH14

1.56e-052110225168025
Pubmed

A genetic approach to Mammalian glycan function.

MGAT2 NDST2

3.22e-053010212676797
Pubmed

A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.

MYH10 MYH14

7.32e-054510222114352
Pubmed

ZF21 is a new regulator of focal adhesion disassembly and a potential member of the spreading initiation center.

MYH10 MYH14

7.65e-054610220890123
Pubmed

SIK2 orchestrates actin-dependent host response upon Salmonella infection.

MYH10 MYH14

9.05e-055010233947818
Pubmed

Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

MYH10 MYH14

1.06e-045410222266860
Pubmed

PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.

MYH10 MYH14

1.63e-046710229735542
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

WDR87 MYH10 MYH14

1.98e-0442110334650049
InteractionH3C1 interactions

WDR87 NAV3 MYH10 NAV2 MYH14

3.69e-05901105int:H3C1
InteractionZIC3 interactions

MYH10 MYH14

6.61e-0525102int:ZIC3
InteractionMYL3 interactions

MYH10 MYH14

6.61e-0525102int:MYL3
InteractionNAV3 interactions

NAV3 NAV2

1.54e-0438102int:NAV3
InteractionNAV2 interactions

NAV3 NAV2

1.98e-0443102int:NAV2
InteractionDPM2 interactions

MYH10 MYH14

3.13e-0454102int:DPM2
CytobandEnsembl 112 genes in cytogenetic band chr19q13

WDR87 MYH14

2.64e-021192102chr19q13
GeneFamilyMyosin heavy chains

MYH10 MYH14

1.79e-0515821098
CoexpressionGSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN

MYH10 MGAT2 NDST2

5.05e-05200103M3260
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

7.40e-06180103b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

7.65e-0618210317ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

7.91e-06184103ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.04e-06185103fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.04e-06185103929b68b05b7686341329ac756d7df172cb4b810b
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.17e-061861034e94158db52df41d71e67b02b9895a358eebee0f
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.17e-06186103e83718fabb057100835d3357df407f283d23fe16
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.30e-06187103201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

NAV3 MYH10 NAV2

8.30e-06187103e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

NAV3 MYH10 NAV2

8.30e-0618710392d468dde81125d51daf7abd4703741abe1ab91c
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.43e-061881034bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2 MYH14

8.43e-061881036164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellfacs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NAV3 MYH14 NDST2

8.43e-06188103c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 MYH10 NAV2

8.84e-061911036688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 MYH10 NAV2

8.98e-0619210399ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 MYH10 NAV2

9.12e-0619310399525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 MYH10 NAV2

9.26e-06194103e93de9428c986b8943fc169258847c650cfab0e5
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

NAV3 MYH10 NAV2

9.41e-0619510361c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

NAV3 MYH10 NAV2

9.41e-06195103603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

NAV3 MYH10 NAV2

9.41e-06195103aa0add081881d349099d12efca5cdee098038d4e
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 MYH10 NAV2

9.55e-061961037d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

NAV2 SLC41A2 MYH14

9.70e-06197103b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 MYH10 NAV2

9.70e-061971030dd71e399f253787fa546a7e90c5373180b89ffd
ToppCellCOPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class

NAV3 MYH10 NAV2

9.70e-06197103d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 MYH10 NAV2

9.85e-061981038f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

NAV3 MYH10 NAV2

9.85e-06198103df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

NAV3 MYH10 NAV2

9.85e-061981033ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 MYH10 NAV2

1.01e-05200103cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 MYH10 NAV2

1.01e-05200103e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass

MYH10 NAV2

3.40e-041251026cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV2 MRPL47

3.84e-04133102292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV2 MRPL47

3.84e-04133102f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCellAdult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor

MYH10 NAV2

4.75e-0414810281a1e6fdd942a612bf523c59b8b4974f6ca1fdce
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 NDST2

4.88e-04150102909ccab92855f5f049dc29593aadab1ea973297b
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

5.69e-04162102d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

5.69e-0416210206f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAV2 SLC41A2

5.69e-041621025c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

5.83e-04164102b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

5.83e-04164102fe11fcce4ba7f44ba2989ea3705916b67e75f8e7
ToppCellfacs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV3 SLC41A2

6.04e-04167102961e722442d786ab15d1e490941d2be265a9057a
ToppCellfacs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV3 SLC41A2

6.04e-041671023760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV2 NDST2

6.04e-04167102bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCellControl|World / group, cell type (main and fine annotations)

NAV2 MYH14

6.12e-04168102a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

WDR87 MYH10

6.19e-04169102563c267edaade0e5df192ad953801ef9768d4270
ToppCelldroplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC41A2 MYH14

6.33e-041711024e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RNF121 NAV2

6.41e-0417210284d16cd7f618c94888920680bdc9e7130d73fd75
ToppCellControl-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations)

NAV2 MYH14

6.56e-04174102548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH10 NAV2

6.63e-041751021799a7be623dc3bf53ba580a7c47d2619969d708
ToppCelldroplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC41A2 MYH14

6.63e-0417510221bc0e59a9509d38751ce6aad2325f341bc70eff
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAV2 SLC41A2

6.71e-041761023bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

6.78e-041771029af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH10 NAV2

6.86e-0417810209475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH10 NAV2

6.86e-0417810235de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH10 NAV2

6.86e-04178102000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV2 SLC41A2

6.86e-04178102a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAV3 MYH10

6.86e-04178102ad3de3e03a401dac64431a541899445262246347
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

6.94e-0417910204ce3673e46606f63d9c87bcba3a64c96817d812
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC41A2 MYH14

6.94e-04179102fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

NAV3 MYH10

6.94e-0417910210fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC41A2 MYH14

6.94e-041791027db6b97a1c4c7a163d5da4351ba36ac1785d9d7b
ToppCellCOVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations)

NAV2 MYH14

6.94e-04179102a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells)

MYH10 NAV2

7.01e-04180102137fc14859c89e1ecd98bee388bb58c04b835847
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV2 SLC41A2

7.01e-04180102b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells)

MYH10 NAV2

7.01e-04180102cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCellLPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC41A2 MYH14

7.09e-041811020513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.09e-04181102b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

7.17e-04182102573771130247e869e4e58f22d4a1cb31989635cf
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NAV2 MYH14

7.17e-041821026cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCellpdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

NAV2 SLC41A2

7.17e-041821027b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.25e-04183102ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellCOVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type

NAV2 MYH14

7.25e-04183102942530449e9c6583705eeb8f6f12621daea57252
ToppCellCOVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type

NAV2 MYH14

7.25e-041831027b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCellCOVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations)

NAV2 MYH14

7.25e-04183102dc1d380bf7564f290256cb7108063d1bd2da732b
ToppCellLPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC41A2 MYH14

7.25e-04183102e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAV3 MYH10

7.25e-041831024d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 MYH14

7.33e-04184102d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 NAV2

7.33e-04184102e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCellP28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAV2 MYH14

7.33e-0418410205811d13bd8a602095a3fcf5e55345edadc7b8bf
ToppCellControl-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.33e-0418410251e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 SLC41A2

7.33e-04184102d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV2 MYH14

7.33e-0418410257c792e6e2fedba25d3350ffe649fd74750b579d
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.33e-041841027cc5796557379c3d1db078c1aeda40659c6e401c
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV2 MYH14

7.41e-041851021c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH10 MYH14

7.41e-04185102a6874dd3030d04380cc3c01de1069461aad4ef45
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

NAV2 MYH14

7.41e-04185102cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellControl-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.41e-041851020d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.41e-041851023937e026add96a396122139daf8011cfbc60e75c
ToppCellMild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

NAV3 NAV2

7.41e-04185102c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCellCOVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations)

NAV3 NAV2

7.41e-04185102a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCellP28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAV2 MYH14

7.41e-041851025bb513e569f3a197d55ae2ca683e202daebabeac
ToppCell5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NAV3 MYH10

7.48e-0418610240070d9cd20188ba49b32acfca9bc16256b38bf5
ToppCellE17.5-Epithelial-alveolar_epithelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAV2 MYH14

7.48e-04186102a7a2ef8392a045a62fa4d0983577711d5d397dc4
ToppCellLPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC41A2 MYH14

7.48e-04186102e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCellCOPD-Epithelial-Club|World / Disease state, Lineage and Cell class

NAV2 MYH14

7.48e-041861023006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCellControl-Epithelial-Club|World / Disease state, Lineage and Cell class

NAV2 MYH14

7.48e-041861029798428691408e17ff2af2fe2d1b345f074d67e4
ToppCellP15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAV2 MYH14

7.48e-04186102521e6e007bbae73e7328153aa170cf04ca3c1093
ToppCellfacs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NAV2 MYH14

7.48e-041861027c4eb769574f9f32753cea1cc38c711dabba88b9
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NAV2 MYH14

7.48e-041861023aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellEpithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor

NAV2 MYH14

7.48e-0418610209d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCellE17.5-Epithelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NAV2 MYH14

7.56e-04187102fdabe716ce67f2eede90548198cbe20bbf693570
DrugFluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A

NAV2 MGAT2 MYH14

6.57e-051901034314_UP
DrugAC1NDLJ6

NAV3 NAV2

7.50e-0530102CID004627775
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

NAV2 MGAT2 MYH14

7.54e-051991037414_UP
DrugPHA-00846566E [724718-26-7]; Down 200; 10uM; MCF7; HT_HG-U133A

NAV2 MYH14 NDST2

7.66e-052001037081_DN
Diseasecorpus callosum anterior volume measurement

NAV3 NAV2

7.61e-0539102EFO_0010295
Diseasecortical surface area measurement, neuroimaging measurement

NAV3 NAV2

2.55e-03227102EFO_0004346, EFO_0010736
Diseaseneuroimaging measurement

NAV3 MYH10 NAV2

4.70e-031069103EFO_0004346
Diseasesmoking behavior

NAV3 NAV2

5.64e-03341102EFO_0004318
Diseasebrain connectivity measurement

NAV3 NAV2

7.68e-03400102EFO_0005210
Diseasecortical surface area measurement

NAV3 MYH10 NAV2

8.91e-031345103EFO_0010736
Diseasebrain measurement, neuroimaging measurement

NAV3 NAV2

1.41e-02550102EFO_0004346, EFO_0004464
DiseaseProstatic Neoplasms

MYH14 NDST2

1.75e-02616102C0033578
DiseaseMalignant neoplasm of prostate

MYH14 NDST2

1.75e-02616102C0376358
Diseaseamino acid measurement

NAV3 MYH10

2.10e-02678102EFO_0005134

Protein segments in the cluster

PeptideGeneStartEntry
KPLWAWWELQSHKHS

nan

91

Q9HAA7
KHHWWWKLHFVWERV

MGAT2

231

Q10469
LRHWQWWRLFTKVKP

MYH14

846

Q7Z406
VKIIDWIPKTWHHLN

NAV3

2211

Q8IVL0
HWQWWRVFTKVKPLL

MYH10

831

P35580
LVKIIDWIPKVWHHL

NAV2

2311

Q8IVL1
LLWIADWMVHHFWRK

SLC41A2

516

Q96JW4
IIWHKFKQWVIPWHL

MRPL47

176

Q9HD33
LLKHRKEFWWFPHMW

NDST2

376

P52849
TVKLHWWRFLVIWIL

RNF121

96

Q9H920
QHKPLGAWWKWFLQH

WDR87

2481

Q6ZQQ6